Metastatic

0

Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer

April 2, 2024

Application based on results from the TROPION-Breast01 phase 3 trial Additional BLA under review in the U.S. for Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan for patients with advanced nonsquamous non-small cell lung cancer TOKYO & BASKING RIDGE, N.J., April 02, 2024–(BUSINESS WIRE)–Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO . . .

0

The impact of race on survival in metastatic prostate cancer: a systematic literature review

August 17, 2023

Overview of included studies Following removal of duplicates, 3228 records were identified from the database searches and screened for inclusion. A total of 173 conference abstracts were identified and screened during the supplemental search. In total, 95 records reporting on 86 unique studies met the eligibility criteria for the SLR. Of these, race and survival […]

0

Metastatic Colon Cancer: How Black Americans Can Get The Best Treatment

February 20, 2023

The Difference of Quality Healthcare In Harris County in Texas, a diverse and heavily populated area that includes the city of Houston, a pioneering program shows just how effective access to evidenced-based care for people with mCRC can be. The public hospital Ben Taub treats a largely uninsured, primarily minority population and is affiliated with […]

0

More Effort is Needed to Inform Black Patients With Metastatic Breast Cancer to Increase Clinical Trial Participation

June 1, 2022

Black patients with metastatic breast cancer are less likely to trust and participate in clinical trials due to a lack of information and assurance of equal treatment, according to the results of a recent survey. Among racial and ethnic groups in the United States, Black patients who have breast cancer have the highest death rate […]

Current track

Title

Artist